Potential and Clinical Translation of Oncolytic Measles Viruses

Expert Opinion on Biological Therapy - United Kingdom
doi 10.1080/14712598.2017.1288713
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Micromanaging Oncolytic Viruses

Science-Business eXchange
2008English

Achieving Systemic Delivery of Oncolytic Viruses

Expert Opinion on Drug Delivery
Pharmaceutical Science
2019English

Targeting Nucleotide Biosynthesis: A Strategy for Improving the Oncolytic Potential of DNA Viruses

Frontiers in Oncology
Cancer ResearchOncology
2017English

Corrigendum: Defects in Interferon Pathways as Potential Biomarkers of Sensitivity to Oncolytic Viruses

Reviews in Medical Virology
VirologyInfectious Diseases
2019English

Oncolytic Viruses: Overcoming Translational Challenges

Journal of Clinical Investigation
Medicine
2019English

Oncolytic Viruses: Immune or Cytolytic Therapy?

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2014English

Sensitivity of Breast Tumors to Oncolytic Viruses

2005English

Oncolytic Viruses: A Step Into Cancer Immunotherapy

Virus Adaptation and Treatment
VirologyInfectious DiseasesImmunology
2011English

639. MicroRNA-Mediated Multi-Tissue-Detargeting of Oncolytic Measles Virus

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy